A guide to cancer types and chemotherapy medications
|
|
|
- Dustin Barrett
- 10 years ago
- Views:
Transcription
1 A guide to cancer types and chemotherapy medications This guides lists words that mean cancer, cancer types and intravenous chemotherapy medications. If you have any questions, see page 10 for details on how to contact Macmillan Cancer Support. Contents Words that mean cancer Cancer types Intravenous chemotherapy medications Words that mean cancer The following list of words are all terms that mean a form of cancer: Adenocarinoma Carcinoma Carcinoid Leukemia Lymphoma Malignant tumour Malignancy Melanoma Questions about cancer? Ask Macmillan Page 1 of 10
2 Mesothelioma Metastasis Myeloma Osteosarcoma Primary tumour Sarcoma Secondary tumour Secondaries Seminoma Teratoma Cancer types Cancer types are listed below: Anal cancer Bile duct cancer (cholangiocarcinoma) Bladder cancer Bone cancer, primary bone Chondrosarcoma Chordoma Ewing s sarcoma Osteosarcoma Bone cancer, secondary Bowel cancer (colorectal cancer) Small bowel cancer Brain tumours Acoustic neuroma Astrocytic tumours CNS lymphoma (central nervous system lymphoma Ependymoma Page 2 of 10 Questions about cancer? Ask Macmillan
3 Haemangioblastoma Medulloblastoma Meningioma Mixed gliomas Oligodendroglioma Pineal region tumours Pituitary tumours Breast cancer Ductal carcinoma in situ (DCIS) Her-2 positive breast cancer Inflammatory breast cancer Lobular carcinoma in situ (LCIS) Paget s disease of the breast Triple negative breast cancer Breast cancer-secondary Cancer of unknown primary (CUP) Carcinosarcoma Cervical cancer Colon cancer Endocrine tumours Adrenal gland tumours Multiple endocrine neoplasia 1 (MEN1) Multiple endocrine neoplasia 2 (MEN2) Pancreatic cancer Parathyroid gland tumours Pituitary gland tumours Thyroid cancer Anaplastic thyroid cancer Follicular thyroid cancer Medullary thyroid cancer Papilliary thyroid cancer Questions about cancer? Ask Macmillan Page 3 of 10
4 Endometrial cancer (type of womb cancer) Eye cancer (ocular melanoma) Gall bladder cancer Gastric cancer (stomach cancer) Gastro-oesophageal cancer Gullet (oesophagus) cancer Head and neck cancer Lip Pharynx pharyngeal Tongue Hepatocellular (type of liver cancer) Hepatoma (type of liver cancer) Kaposi s sarcoma (KS) Kidney cancer Laryngeal cancer (Larynx cancer, cancer of the voice box) Leukaemia Acute lymphoblastic Acute myeloid Acute erythroleukaemia Acute megakaryoblastic leukaemia Acute monocytic/monoblastic leukaemia Acute myelomonocytic leukaemia Acute promyelocytic leukaemia (APL) Chronic lymphocytic Chronic myeloid Liver cancer Liver cancer, secondary Lung cancer Mesothelioma Peritoneal mesothelioma Page 4 of 10 Questions about cancer? Ask Macmillan
5 Pleural mesothelioma Non-small cell lung cancer (NSCLC) Pulmonary blastoma Small-cell lung cancer Lung cancer, secondary Lymph node cancer, secondary Lymphoma Hodgkin Non-Hodgkin Burkitt lymphoma Diffuse large B-cell lymphoma Follicular lymphoma Lymphoplasmacytic lymphoma MALT lymphoma (mucosa associated lymphoid tissue) Mediastinal large B-cell lymphoma Nodal marginal zone B-cell lymphoma Small lymphocytic lymphoma Lymphoplasmacytic lymphoma Malignant Tumours Melanoma Acral melanoma Advanced melanoma Lentigo maligna melanoma Melanoma 1mm and over Nodular Superficial spreading melanoma Thin melanoma Mesothelioma Peritoneal mesothelioma Pleural mesothelioma Questions about cancer? Ask Macmillan Page 5 of 10
6 Myeloma Plasmacytoma Neuroendocrine tumours Carcinoid Gastrinoma Glucagonoma Insulinoma Somatastatinoma VIPoma Occult primary tumour Ovarian cancer Pancreatic cancer Penis cancer Primary liver cancer Primary peritoneal Primitive neuroectodermal tumour (PNET) Prostate cancer Prostatic cancer Prostatic intraepithelial neoplasia (PIN) Pseudomyxoma peritonei (PMP) Rare cancers Rectal cancer Renal cancer Skin cancer Basal cell cancer BCC (rodent ulcer) Melanoma Acral melanoma Advanced melanoma Lentigo maligna melanoma Melanoma 1mm and over Page 6 of 10.. Questions about cancer? Ask Macmillan
7 Nodular Superficial spreading melanoma Thin melanoma Melanoma in situ Non-melanoma skin cancer Squamous cell cancer (SCC) Soft tissue sarcomas Angiosarcomas Desmoid tumours Ewing s tumours Fibrosarcomas Gastrointestinal stromal tumours (GISTs) Kaposis sarcoma (KS) Leiomyosarcomas Liposarcomas Malignant peripheral nerve sheath tumours (MPNST) Myxofibrosarcomas Other sarcomas Rhabdomyosarcomas Synovial sarcomas Spinal cord tumours Stomach cancer Testicular cancer Nonseminomatous germ cell tumour (NSGCT) Seminoma Teratoma Thymus cancer Thymic carcinoma Thymoma Questions about cancer? Ask Macmillan Page 7 of 10
8 Thyroid cancer Anaplastic thyroid cancer Follicular thyroid cancer Medullary thyroid cancer Papilliary thyroid cancer Trachea (windpipe) cancer Unknown primary cancer (UPC) Unknown primary tumour (UPT) Vagina cancer Vulva cancer Waldenstrom s macroglobulinaemia Womb (uterus) cancer Intravenous (IV) chemotherapy drugs Here is a list of intravenous (IV) chemotherapy drugs: Amsacrine - Amsidine Bleomycin Busulfan - Busilvex Carboplatin Carmustine Cisplatin Cladribine - Leustat Clofarabine - Evoltra Crisantaspase - Erwinase Cyclophosphamide Cytarabine Dacarbazine Dactinomycin Cosmegen, Lyovac Daunorubicin - DaunoXome (Cerubidin was formerly used) Page 8 of 10 Questions about cancer? Ask Macmillan
9 Docetaxel - Taxotere Doxorubicin - Caelyx / Myocet (both lipid formulations for IV), (NB Adriamycin was formerly used) Epirubicin - Pharmorubicin Etoposide - Etopophos / Eposin Fludarabine - Fludara Fluorouracil Gemcitabine - Gemzar Idarubicin - Zavedos Ifosfamide Irinotecan - Campto Melphalan - Alkeran Methotrexate Mitomycin - Mitomycin C Kyowa Mitoxantrone - Onkotrone Oxaliplatin - Eloxatin Paclitaxel - Abraxane / Taxol Pemetrexed - Alimta Pentostatin - Nipent Raltitrexed - Tomudex Streptozocin - Zanosar Teniposide Vumon, VM-26 Thiotepa Tioguanine Lanvis / 6-Thioguanine Topotecan - Hycamtin Treosulfan Treosulfan Vinblastine - Velbe Vincristine - Oncovin Vindesine - Eldisine Vinorelbine - Navelbine Questions about cancer? Ask Macmillan Page 9 of 10
10 More information and support If you have any questions about cancer, ask Macmillan. If you need support, ask Macmillan. Or if you just want someone to talk to, ask Macmillan. Our cancer support specialists are here for everyone living with cancer, whatever you need. Call free on , Monday Friday, 9am 8pm We make every effort to ensure that the information we provide is accurate but it should not be relied upon to reflect the current state of medical research, which is constantly changing. If you are concerned about your health, you should consult your doctor. Macmillan cannot accept liability for any loss or damage resulting from any inaccuracy in this information or third party information such as information on websites to which we link. Macmillan Cancer Support Registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Registered office 89 Albert Embankment, London, SE1 7UQ Page 10 of 10 Questions about cancer? Ask Macmillan
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted
MODERN IMMUNOHISTOCHEMISTRY
MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,
Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment
A Patient s Guide Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment Recommendations of the American Society of Clinical Oncology The American Society of Clinical Oncology (ASCO) is
Chapter I Overview Chapter Contents
Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality
Medications most likely to be seen in primary care
Hazardous Medicines The majority of medicines are not classed as hazardous. The only medicinal products that are automatically deemed to be hazardous are cytotoxic and cytostatic medicines. There is no
Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12
Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background
Immunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
Pediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin
A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,
Avastin: Glossary of key terms
Avastin: Glossary of key terms Adenocarcinoma Adenoma Adjuvant therapy Angiogenesis Anti-angiogenics Antibody Antigen Avastin (bevacizumab) Benign A form of carcinoma that originates in glandular tissue.
4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma
Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer
Chemotherapy for non-small cell lung cancer
Chemotherapy for non-small cell lung cancer This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 3. Contents
Hospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University
Hospital-Based Tumor Registry Srinagarind Hospital, Khon Kaen University Statistical Report 2012 Cancer Unit, Faculty of Medicine Khon Kaen University Khon Kaen, Thailand Tel & Fax:+66(43)-202485 E-mail:
This module consists of four units which will provide the user a basic knowledge of cancer as a disease.
Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define
BRAIN TUMOUR RESEARCH FUNDING FLOWS
BRAIN TUMOUR RESEARCH FUNDING FLOWS Ellen Harries, Iona Joy v London, April 2013 (updated) CONTENTS 1 Research brief and headline findings 2 Research funding for cancer 3 Brain tumour funding compared
Locoregional & advanced esophagus or esophagogastric junction cancer
Eloxatin (oxaliplatin) Prior Authorization Request (For Maryland Only) Send completed form to: Case Review Unit CVS/caremark Specialty Programs Fax: 866-249-6155 CVS/caremark administers the prescription
The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales
The effect of the introduction of ICD-10 on cancer mortality trends in Anita Brock, Clare Griffiths and Cleo Rooney, Offi ce for INTRODUCTION From January 2001 deaths in have been coded to the Tenth Revision
Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701)
Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701) Contractor Information Contractor Name Cahaba Government Benefit Administrators, LLC Article Information General Information
NEOPLASMS C00 D49. Presented by Jan Halloran CCS
NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through
Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations
North America Canada Canadian 1951 Schmidt & Popham (1981) 1951 70 9 889 alcoholic men, aged 15 years, admitted to the clinical service of the Addiction Research Foundation of Ontario between Death records
Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there
Friend for Life Cancer Support Network Annual Report 2010 Facing cancer, with someone who s been there This is wonderful support for those of us who are newly diagnosed with cancer. Our Mission To help
About lung cancer. Contents. The lungs
This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 7. The lungs Contents The lungs Types of lung cancer
Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is
How CanCer becomes critical in the claims
How CanCer becomes critical in the claims arena Cancer is a disease in which cells in your body grow in an uncontrolled way and form a lump called a tumour. In a healthy individual cells grow and reproduce
Non-Hodgkin Lymphoma Richard Orlowski, MD
Non-Hodgkin Lymphoma Richard Orlowski, MD The American Cancer Society (ACS) estimates that 69,740 Americans will be diagnosed with non-hodgkin lymphoma (NHL) in 2013. Excluding non-melanoma skin cancers,
The brain structure and function
The brain structure and function This information is an extract from the booklet Understanding brain tumours. You may find the full booklet helpful. We can send you a copy free see page 5. Contents Introduction
Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT
Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT NCCN guidelines were reviewed on 3/25/2013 for utilization of 18 F-fluorodeoxyglucose (FDG) PET and PET/CT (available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp).
Chemotherapy for lung cancer
This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 8. Contents Chemoradiation Small cell lung cancer
Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.
Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic
PROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
New Hampshire Childhood Cancer
Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children
Second Cancers Caused by Cancer Treatment
Second Cancers Caused by Cancer Treatment Advances in radiation therapy and chemotherapy have increased the chances of survival for many people with cancer today. People with cancer are often living longer,
Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach
Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society
C a nc e r C e nter. Annual Registry Report
C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases
Hydration, IV Infusions, Injections and Vaccine Charge Process
There are a number of items to be considered when billing for the Nursing service to perform drug therapy, the charge process is divided into three specific groups of codes and processes. 1. Hydration
CANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer
MEDIA FACTSHEET CANCER EXPLAINED What is cancer? Cancer is a disease which occurs when changes in a group of normal cells within the body lead to uncontrolled growth causing a lump called a tumour; this
Treating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
A23: Oncologic Disease- Tumor Markers
A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of
BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer ABOUT ME
BreastCancerTrials.org History Form: Completed Treatment for Breast Cancer This form is for patients with DCIS or early stage invasive cancer who are: On hormone therapy after breast cancer surgery Or
APPENDIX: CHEMOTHERAPY SIDE EFFECT PROFILES
APPENDIX: CHEMOTHERAPY SIDE EFFECT PROFILES All chemotherapy drugs can cause side effects. No one can predict ahead of time what side effects you may experience or their severity. Some people experience
Leukaemia and lymphoma what s the difference?
Freephone helpline 0808 808 5555 [email protected] www.lymphomas.org.uk Leukaemia and lymphoma what s the difference? This is a difficult question to answer simply but it is one that is often
Number. Source: Vital Records, M CDPH
Epidemiology of Cancer in Department of Public Health Revised April 212 Introduction The general public is very concerned about cancer in the community. Many residents believe that cancer rates are high
Treatment of colon cancer
Treatment of colon cancer This information is an extract from the booklet, Understanding colon cancer. You may find the full booklet helpful. We can send you a copy free see page 5. Contents How treatment
MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)
MALIGNANT LYMPHOMAS Dr. Olga Vujovic (Updated August 2010) Malignant lymphomas consist of Hodgkin and non-hodgkin lymphomas. The current management of these diseases involves a multi-disciplinary approach.
Cancer in Western Australia: Incidence and mortality 2003 and Mesothelioma 1960-2003
Cancer in Western Australia: Incidence and mortality 2003 and Mesothelioma 1960-2003 A report of the Western Australian Cancer Registry Health Data Collections, Information Collection and Management Department
Acute Lymphoblastic Leukaemia
1 Royal Marsden and St Georges NHS Foundation Trusts PTC list of approved chemotherapy regimens 2015 Protocol Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemia and Lymphoblastic Lymphoma UKALL
Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control
Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with
Lung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
National Cancer Drugs Fund List (Updated 13 February 2014)
National Cancer Drugs Fund List (Updated 13 February 2014) DRUG Abiraterone Aflibercept Axitinib Bendamustine NCDF APPROVED CRITERIA The treatment of metastatic castration resistant prostate cancer where
Immunohistochemistry of soft tissue tumors
Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated
Graft-versus-host disease (GvHD)
Graft-versus-host disease (GvHD) This information is an extract from the booklet Understanding donor stem cell (allogeneic) transplants. You may find the full booklet helpful. We can send you a free copy
Local Coverage Determination (LCD): Immunohistochemistry (L34369)
Local Coverage Determination (LCD): Immunohistochemistry (L34369) Contractor Information Contractor Name CGS Administrators, LLC LCD Information Document Information LCD ID L34369 Original ICD9 LCD ID
Cancer in Ireland 2013: Annual report of the National Cancer Registry
Cancer in 2013: Annual report of the National Cancer Registry ABBREVIATIONS Acronyms 95% CI 95% confidence interval APC Annual percentage change ASR Age standardised rate (European standard population)
Acute myeloid leukaemia (AML) in children
1 61.02 Acute myeloid leukaemia (AML) in children AML can affect children of any age, and girls and boys are equally affected. Leukaemia Acute myeloid leukaemia (AML) FAB classification of AML Causes of
Chemotherapy for pancreatic
Chemotherapy for pancreatic cancer 1 Chemotherapy for pancreatic cancer This information is from the booklet Understanding pancreatic cancer. You may find the full booklet helpful. We can send you a free
NICE guideline Published: 23 June 2015 nice.org.uk/guidance/ng12
Suspected : recognition and referral NICE guideline Published: 23 June 2015 nice.org.uk/guidance/ng12 NICE 2015. All rights reserved. Contents Introduction... 5 Safeguarding children... 6 Patient-centred
THE CANCER CENTER 2013 ANNUAL REPORT CONTAINING 2012 STATISTICS
THE CANCER CENTER 2013 ANNUAL REPORT CONTAINING 2012 STATISTICS Northside Medical Center Cancer Committee Mission Statement It is the mission of the Cancer Committee to evaluate and monitor the care of
Pathology of lung cancer
Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu
Co-pay assistance organizations offering assistance
Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin
Chemotherapy for head and neck cancers
Chemotherapy for head and neck cancers This information is from the booklet Understanding head and neck cancers. You may find the full booklet helpful. We can send you a free copy see page 7. Contents
DELRAY MEDICAL CENTER. Cancer Program Annual Report
DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions
CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
How To Take A Bone Marrow Transplant
Drug treatments to protect your bones This information is an extract from the booklet, Bone health. You may find the full booklet helpful. We can send you a copy free see page 5. Contents Bisphosphonates
Male Health Issues. Survivorship Clinic
Male Health Issues The effects of cancer therapy on male reproductive function depend on many factors, including the boy s age at the time of cancer therapy, the specific type and location of the cancer,
Surgery and cancer of the pancreas
Surgery and cancer of the pancreas This information is an extract from the booklet Understanding cancer of the pancreas. You may find the full booklet helpful. We can send you a free copy see page 8. Introduction
CHEMOTHERAPY PROTOCOLS V10.1
CHEMOTHERAPY PROTOCOLS V10.1 Issue Date: 10 th July 2014 Page 1 of 42 Filename: MCHACPROTO Issue No: 10.1 CCC Chemotherapy Protocols Haematological Malignancies... 3 Hodgkins disease...3 Non-Hodgkins Lymphoma...5
Lung Cancer Treatment: What should we expect from the specialists?
Lung Cancer Treatment: What should we expect from the specialists? Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 2015 Summer CME Seminar Financial
Understanding Metastatic Disease
Supported by an unrestricted educational grant from Pfizer Understanding Metastatic Disease Metastatic disease or metastases are phrases that mean the same as Secondary cancer. This means that the cancer
43,303,919 paid out in critical illness claims in the first six months of 2012*
Critical Illness Claims Report 43,303,919 out in critical illness claims in the first six months of 2012* 60 % Cancer 16 % Heart Attack 10 % Other 3 % Benign Brain Tumour 5 % Multiple Sclerosis 6 % Stroke
How treatment is planned Giving your consent The benefits and disadvantages of treatment Second opinion
Treatment overview for lung cancer This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 5. Contents How
Understanding your pathology report
Understanding your pathology report 2 Contents Contents Introduction 3 What is a pathology report? 3 Waiting for your results 4 What s in a pathology report? 4 Information about your breast cancer 5 What
Policy Wording. Together, all the way.
Cancer cover Policy Wording Together, all the way. Cancer Cover Insurance Policy Wording 1. Introducing your Policy 2. What is Cancer Cover Insurance? 3. About your Policy 4. Some terms defined 5. What
List of Qualifying Conditions
List of Qualifying Conditions Cancer Conditions 1) Adrenal cancer 2) Bladder cancer 3) Bone cancer all forms 4) Brain cancer 5) Breast cancer 6) Cervical cancer 7) Colon cancer 8) Colorectal cancer 9)
A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on
A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on examination. She also has fever, weight loss, and sweats. What
Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver
Topic-Adenocarcinoma, Lung Figure 1. Pulmonary adenocarcinoma. Figure 2. Pulmonary bronchiolar carcinoma. Figure 3. Pulmonary fibrosarcoma. Topic-Adenocarcinoma, Skin (Sweat Gland, Sebaceous) Figure 1.
Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.
Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific
Guidelines for the Management of. Nausea and Vomiting in Cancer Patients
Guidelines for the Management of Nausea and Vomiting in Cancer Patients Guidelines for the Management of Nausea and Vomiting in Cancer Patients Management of chemotherapy-induced nausea and vomiting includes
The Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.
of 22 I. Purpose To establish safe medication practices for High Alert medications to maximize the safety of the medication processes associated with these medications. II. Policy. High alert medications
Radiotherapy for breast cancer
Radiotherapy for breast cancer This information is an extract from the booklet Understanding breast cancer. You may find the full booklet helpful. We can send you a copy free see page 6. Contents Radiotherapy
Radiotherapy for vulval cancer
This information is an extract from the booklet Understanding cancer of the vulva. You may find the full booklet helpful. We can send you a copy free see page 6. Contents External radiotherapy Internal
52,929,390 paid out in critical illness claims in the first six months of 2013*
Critical Illness Report (January to June 2013) 52,929,390 paid out in critical illness claims in the first six months of 2013* 66 % Cancer 12 % Heart Attack 9 % Other 3 % Benign Brain Tumour 4 % Multiple
Leukemias and Lymphomas: A primer
Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes
Radioactive iodine treatment for thyroid cancer
Radioactive iodine treatment for thyroid cancer This information is an extract from the booklet, Understanding thyroid cancer. You may find the full booklet helpful. We can send you a copy free see page
Presumptive Cancers Due to Agent Orange Exposure & Cholangiocarcinoma (Bile Duct - Liver Fluke Cancer)
Presumptive Cancers Due to Agent Orange Exposure & Cholangiocarcinoma (Bile Duct - Liver Fluke Cancer) Presumptive Cancers Due to Agent Orange Exposure Prostate Cancer - Cancer of the prostate; one of
A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins [email protected] 514-426- 9295 www.rarepa;entvoice.
A Source of Hard- to- Find Pa3ents and Caregivers For Researchers Peter Ziedins [email protected] 514-426- 9295 www.rarepa;entvoice.com About RPV Rare Pa3ent Voice, LLC was formed to provide